Skip to content

Trial · Interventional

CompletedNot applicableRegistry data

Topical Acetyl Hexapeptide-8 and the Cosmetic Appearance of Oily Skin

NCTNCT02597777 (opens ClinicalTrials.gov in a new tab)Other id691537
Open at ClinicalTrials.govAsk about this trial

Overview

Status
Completed
Phase
Not applicable
Enrollment
14 participants (actual)
Sponsor
University of California, Davis · Other
Design
Randomized · Quadruple masking
Countries
1 country

United States

Start
Jan 2016
Primary completion
Feb 2016
Completion
Feb 2016
First posted
5 Nov 2015 (estimated)
Last update posted
5 Apr 2017
Conditions
Oily Skin

Timeline

1 trial · 1 completed

  • Completed
  • Ongoing
  • Not yet recruiting
  • Stopped
  • Estimated dates (est.)
  • Results posted
20162017
  1. N/A

    Topical Acetyl Hexapeptide-8 and the Cosmetic Appearance of Oily Skin

    NCT02597777

    Jan 2016 to Feb 2016

Registry summary

Text and fields below are the sponsor's entries at ClinicalTrials.gov, shown as posted.

This is a randomized double-blinded study examining the effect of topical Acetyl Hexapeptide-8 AH8) for improving the cosmetic appearance and experience of oily skin.

Interventions

  • Acetyl Hexapeptide-8Other
  • Placebo vehicleOther

Arms2

  • Placebo comparator

    Side of face receiving placebo vehicle

    One half of the face (left or right side) will be randomized to receive the placebo lotion. Subjects will be asked to apply a pea-sized amount of the lotion to half of the face at twice daily application for 4 weeks.

  • Experimental

    Side of face receiving AH8 lotion

    One half of the face (left or right side) will be randomized to receive the 10% Acetyl Hexapeptide-8 containing (AH8) lotion. Subjects will be asked to apply a pea-size amount of the lotion to the half of the face twice daily application for 4 weeks.

Primary outcomes1

Outcomes the sponsor listed as primary.

  1. Physician graded shine score

    Time frame · 4 weeks

Secondary outcomes(10)

  1. Patient satisfaction rated by each patient using the Oily Skin Self-Assessment Scale (OSSAS)

    Time frame · 2 week

  2. Patient satisfaction rated by each patient using the Oily Skin Self-Assessment Scale (OSSAS)

    Time frame · 4 week

  3. Assessment for local irritation from the topical emulsions

    Time frame · 4 weeks

    Registry description

    Secondary safety endpoint

  4. Physician graded oiliness score

    Time frame · 2 weeks

  5. Physician graded oiliness score

    Time frame · 4 weeks

  6. Sebum measurement

    Time frame · 2 weeks

  7. Sebum measurement

    Time frame · 4 weeks

  8. Patient satisfaction rated by each patient using the Oily Skin Impact Scale (OSIS)

    Time frame · 2 weeks

  9. Patient satisfaction rated by each patient using the Oily Skin Impact Scale (OSIS)

    Time frame · 4 weeks

  10. Physician graded shine score

    Time frame · 2 weeks

Posted results

Values are shown as posted at ClinicalTrials.gov, with their units. PepBank has not converted, pooled or compared them.

No results are posted for this trial.

Completed trials do not always post results.

Registry data comes from ClinicalTrials.gov. Study results come from studies, not from the registry. How PepBank works

Studies0

Studies that cite this trial.

No study cites this trial.

Eligibility

Who could join, as posted.

Sex
All
Age
from 18 Years
Healthy volunteers
Accepted
Inclusion and exclusion criteria, as posted
Inclusion Criteria: * Subjects over the age of 18 Exclusion Criteria: * Recent intradermal botulinum neurotoxin injection within the last 6 months. * Known hypersensitivity to AH8 * Ablative resurfacing procedures to the face within 6 months of the study initiation * Report of pregnancy or breastfeeding * Use of immunosuppressive drugs

PepBank is a research reference. Talk to a doctor before you use any peptide.